PharmCADD moved into Cambridge Innovation Center (CIC) in Boston, USA. <View Original Article> PharmCADD moved into Cambridge Innovation Center (CIC) in Boston, USA. 더 읽기"
PharmCADD introduced AI drug development progress to the ‘BIO KOREA 2021’ <View Original Article> PharmCADD introduced AI drug development progress to the ‘BIO KOREA 2021’ 더 읽기"
Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021 <View Original Article> Prime Minister Kim Boo-kyum visited the booth of PharmCADD in BIO KOREA 2021 더 읽기"
[ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation. [ISSUE COMPANY] PharmCADD has developed an AI-based new drug discovery platform ‘Pharmulator’ that improves accuracy with quantum calculation. 더 읽기"
PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards. <View Original Article> PharmCADD CTO, Dr. Sangwook Wu won the Ministry of Science and ICT awards. 더 읽기"
South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO. <View Original Article> South Korea’s Pharmcadd bags $16M in series B financing, plans 2022 IPO. 더 읽기"
PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect. <View Original Article> PharmCADD researched network theory to develop new drugs for the safety from toxicity and side effect. 더 읽기"
PharmCADD Raised $16M in Series B Funding. <View Original Article> PharmCADD Raised $16M in Series B Funding. 더 읽기"
Eyegene published a nonclinical paper COVID-19 vaccine on BioRxiv. <View Original Article> Eyegene published a nonclinical paper COVID-19 vaccine on BioRxiv. 더 읽기"
PharmCADD showed AI drug development platform, Pharmulator at AI EXPO in korea. <View Original Article> PharmCADD showed AI drug development platform, Pharmulator at AI EXPO in korea. 더 읽기"